About Us
Our Research and Data Matter
An in-vitro and in-vivo study published in the Journal of Investigative Dermatology in February 2015 found that treatment with delta-tetrahydrocannabinol and Cannabidiol helped to decrease the viability of melanoma cells.
Research and Development Motivations
Our founder and CEO is particularly motivated to bring the Company's research and product development to children suffering from DIPG, having been personally exposed to the challenge of a child and his family and the lack of treatment available to ease suffering. We know there is a significant opportunity to make a clinical impact in these situations merely by researching this alternative.
Additional Neuro Focus CTE in NFL, PTSD.
Thought Leaders and Educators in Cannabidiol Research and Development
As research and Development evolve with merging medical markets, it is our desire to ensure we educate and increase awareness to the impact Cannabidiol Research can have and potentially deliver to future generations of children. We speak with many Clinicians and Researchers across the International Scientific Market and feel honored to be apart of this merging scientific research and data collection.